Distribution of yeast species associated with oral lesions in HIV-infected patients in Southwest Uganda

Medical Mycology

Volumn 50, Issue 3, 2012, Pages 276-280

  Agwu, Ezera ^a   Ihongbe, John C ^b   McManus, Brenda A ^c   Moran, Gary P ^c   Coleman, David C ^c   Sullivan, Derek J ^c  

^a KAMPALA INTERNATIONAL UNIVERSITY   (Uganda)

^b AMBROSE ALLI UNIVERSITY   (Nigeria)

^c DUBLIN DENTAL UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Candida; HIV; Oropharyngeal candidiasis; Prevalence; Yeast species

Indexed keywords

AGAR; CLOTRIMAZOLE; GLUCOSE; NYSTATIN;

ADULT; AGED; APHTHOUS ULCER; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CHEILITIS; CHILD; DISEASE ASSOCIATION; FEMALE; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OROPHARYNX CANDIDIASIS; PRESCHOOL CHILD; SAMPLE; SCHOOL CHILD; SPECIES DISTRIBUTION; UGANDA; YEAST;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, ORAL; CHILD; CLOTRIMAZOLE; CULTURE MEDIA; FEMALE; HIV INFECTIONS; HUMANS; MALE; MICROBIOLOGICAL TECHNIQUES; MIDDLE AGED; MYCOLOGY; NYSTATIN; UGANDA; YOUNG ADULT;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA TROPICALIS; PICHIA NORVEGENSIS;

EID: 84858411468     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.604862     Document Type: Article

References (27)

1. Calderone RA. Introduction and historical perspectives. In: Calderone RA (ed.), Candida and Candidiasis, 1st edn. Washington, DC: ASM Press, 2002: 3-13.
2. Greenspan JS, Greenspan D. The epidemiology of the oral lesions of HIV infection in the developed world. Oral Dis 2002; 8 (Suppl. 2): 34-39. (Pubitemid 41758938)
3. Coleman DC, Bennett DE, Sullivan DJ, et al. Oral Candida in HIV infection and AIDS: new perspectives/new approaches. Crit Rev Microbiol 1993; 19: 61-82. (Pubitemid 23182147)
4. Schmidt-Westhausen AM, Priepke F, Bergmann FJ, Reichart PA. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 2000; 29: 336-341. (Pubitemid 30459306)
5. Hood S, Bonington A, Evans J, Denning D. Reduction in oropharyn-geal candidiasis following introduction of protease inhibitors. AIDS 1998; 12: 447-448. (Pubitemid 28077549)
6. Tirwomwe JF, Rwenyonyi CM, Muwazi LM, Besigye B, Mboli F. Oral manifestations of HIV/AIDS in clients attending TASO clinics in Uganda. Clin Oral Investig 2007; 11: 289-292.
7. Hamza OJ, Matee MI, Moshi MJ, et al. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal can-didiasis. BMC Microbiology 2008; 8: 135.
8. Thompson GR 3rd, Patel PK, Kirkpatrick WR, et al. Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 2010; 109: 488-495.
9. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-in-fected individuals. Microbiology 1995; 141: 1507-1521.
10. Agwu E, Ihongbe JC, Tirwomwe JF, et al. Appraisal of oral lesions status of HIV/AIDS patients in South Western Uganda. Braz J Oral Sci 2008; 7: 1591-1595.
11. World Health Organization. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children. Geneva: The World Health Organization; 2006.
12. EC-Clearinghouse. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993; 22: 289-291.
13. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994; 32: 1923-1929. (Pubitemid 24222272)
14. Al-Mosaid A, Sullivan DJ, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on Pal's Agar. J Clin Microbiol 2003; 41: 4787-4789. (Pubitemid 37259795)
15. Sahand IH, Maza JL, Eraso E, et al. Evaluation of CHROM-Pal medium for the isolation and direct identification of Candida dublinien-sis in primary cultures from the oral cavity. J Med Microbiol 2009; 58: 1437-1442.
16. Donnelly SA, Sullivan DJ, Shanley DB, Coleman DC. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 1999; 145: 1871-1882. (Pubitemid 29396917)
17. McManus BA, McGovern E, Moran GP, et al. Microbiological screening of Irish autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients reveals persistence of Candida albi-cans strains, gradual reduction in susceptibility to azoles and incidences of clinical signs of oral candidiasis without culture evidence J Clin Microbiol 2011; 49: 1879-1889.
18. Enwuru CA, Ogunledun A, Idika N, et al. Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. Afr Health Sci 2008; 8: 142-148.
19. Melo NR, Taguchi H, Culhari VP, et al. Oral candidiasis of HIV-infected children undergoing sequential HIV therapies. Med Mycol 2009; 47: 149-156.
20. Hood SV, Moore CB, Denning DW. Isolation of Candida norvegensis from clinical specimens: four case reports. Clin Infect Dis 1996; 23: 1185-1187. (Pubitemid 26367519)
21. Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 2010; 48: 1366-1377.
22. Sullivan DJ, Moran GP, Coleman DC. Candida dubliniensis: ten years on. FEMS Microbiol Lett 2005; 253: 9-17. (Pubitemid 41605389)
23. Kibbler CC, Ainscough S, Rosemary A. Barnes, et al. Management and outcome of blood stream infections due to Candida species in England and Wales. J Hosp Infect 2003; 54: 18-24. (Pubitemid 38002021)
24. Sullivan D, Coleman D. Candida dubliniensis: characteristics and identification. J Clin Microbiol 1998; 36: 329-334. (Pubitemid 28060290)
25. Al Mosaid A, Sullivan D, Salkin IF, Shanley D, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on Staib agar and caffeic acid-ferric citrate agar. J Clin Microbiol 2001; 39: 323-327. (Pubitemid 32059611)
26. Blignaut E. Oral candidiasis and oral yeast carriage among institutionalised South African paediatric HIV/AIDS patients. Mycopathologia 2007; 163: 67-73.
27. Blignaut E, Pujol C, Joly S, Soll DR. Racial distribution of Candida dubliniensis colonization among South Africans. J Clin Microbiol 2003; 41: 1838-1842. (Pubitemid 36576500)